DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 87 filers reported holding DICE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.37 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $833,864 | +22.9% | 17,948 | -24.2% | 0.00% | – |
Q1 2023 | $678,719 | +26.9% | 23,690 | +38.2% | 0.00% | – |
Q4 2022 | $534,643 | +128.5% | 17,136 | +48.6% | 0.00% | – |
Q3 2022 | $234,000 | +12.5% | 11,534 | -14.1% | 0.00% | – |
Q2 2022 | $208,000 | +35.1% | 13,424 | +66.6% | 0.00% | – |
Q1 2022 | $154,000 | -28.0% | 8,056 | -4.8% | 0.00% | – |
Q4 2021 | $214,000 | – | 8,463 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Northpond Ventures, LLC | 3,292,871 | $102,737,575 | 55.73% |
Sands Capital Ventures, LLC | 2,748,970 | $85,768 | 23.49% |
OUP Management Co., LLC | 268,346 | $8,372,395 | 13.67% |
New Leaf Venture Partners, L.L.C. | 371,693 | $11,596,822 | 8.40% |
RA Capital Management | 6,848,911 | $213,686,023 | 4.33% |
VR Adviser, LLC | 819,000 | $25,552,800 | 4.30% |
SVB FINANCIAL GROUP | 42,358 | $1,321,570 | 3.61% |
Logos Global Management LP | 660,000 | $20,592,000 | 2.41% |
Deep Track Capital, LP | 1,734,143 | $54,105,262 | 2.27% |
Samsara BioCapital, LLC | 202,773 | $6,326,518 | 1.36% |